European Frontrunners Columnist, Cheryl Barton, focuses on European biotechs leveraging AI, multi-omics, and cell therapies to address the root causes of cardiovascular disease, driving a market ...

Full FDA approval covers proteinuria reduction in FSGS without nephrotic syndrome, a defined clinical subset differentiated ...

In this clip from episode 1 of Manufacturing Intelligence, Richard Jaenisch of Open Biopharma discusses uses of AI for ...

Andrew Chang and Steven Falcone, Novo Nordisk, discuss GMP mutual recognition, real-time digital monitoring, and the future ...

Understand the strategic drivers behind Tjoapack’s US expansion and how increasing packaging capacity supports growing client ...

Andrew Chang, senior director for Quality and Regulatory Affairs, Novo Nordisk, and Steven Falcone, head of the AIR-Q Group, ...

In part 1 of a multi-part series, David Schoneker, president, Black Diamond Regulatory Consulting, explains the difference ...

Global CPHI events underscore international sourcing and partnership dynamics, with Shanghai’s CPHI & PMEC China illustrating ...

Financial terms include $40 million upfront for four programs, expansion options, and opt-out economics up to $535 million per program plus low double-digit royalties, totaling up to $2.1 billion.

Uhlmann Pac-Systeme highlights PTC 200 mono-cartoning for parenterals and BEC 500 blister–cartoner integration, with digital ...

In this clip from episode 1 of Manufacturing Intelligence, Richard Jaenisch of Open Biopharma discusses step 1 in adopting AI ...

Continuous human oversight across design, validation, and operational deployment is positioned as the primary control to ...